VSee Health, Inc. (VSEE)

VSee Health's stock price has declined significantly over the past six months and year. In October 2025, the company announced a teleradiology contract projected to generate $10 million in revenue. In April 2026, it reported 40% year-over-year revenue growth for 2025. In March 2026, VSee unveiled an autonomous telehealth AI robot. In February 2026, a strategic partnership with GoMyRx was announced. In January 2026, a partnership with DocBox was announced to launch an augmented intelligence platform for Virtual ICUs. In April 2026, VSee Health filed an amendment to its S-1 registration to include auditor consents.

There is no explicit indication of significant demand seasonality for VSee Health's products and services. The company's focus on scaling telehealth services and contract-driven growth suggests a continuous demand model rather than seasonal fluctuations.

VSee Health, Inc. is a telehealth technology company providing a secure SaaS platform for virtual care, enabling clinicians and enterprises to create and integrate telehealth workflows. Its offerings include VSee Clinic, VSee Messenger, VSee APIs, and VSee Remote Patient Monitoring, featuring video visits, messaging, collaboration tools, and EHR integration. The company also provides solutions for critical shortage areas and has introduced an autonomous telehealth AI robot.

VSee Health has a global presence, with services in over 50 countries, including Iraq, Syria, the Marshall Islands, and El Salvador. Domestically, it targets large Integrated Health Networks across the USA and aims to expand to as many as 20 states in 2026. Clients include NASA, the U.S. Department of Health and Human Services, McKesson, Magellan, DaVita, GE, and the country of Qatar.

VSee Health has a reputation as a leader in AI-powered telehealth, supported by its use by organizations like NASA and the U.S. Department of Health and Human Services. Its focus on secure, HIPAA-compliant solutions and customizable platform enhances its brand image. Positive events include revenue growth, unveiling an AI robot, and forming strategic partnerships. However, the company has faced challenges including stock decline, short-seller activity, concerns about its ability to continue as a going concern, material weaknesses in internal controls, and a "Red zone" classification by TradeSmith.

VSee Health has a diverse ownership structure including HB Wealth Management, LLC, Geode Capital Management, Llc, Advisor Group Holdings, Inc., Virtu Financial LLC, Jane Street Group, Llc, Two Sigma Securities, Llc, UBS Group AG, JustInvest LLC, State Street Corp, and Wealthcare Advisory Partners LLC. Individual insiders hold approximately 17.4% of the shares, institutions hold about 4.81%, hedge funds hold 7.58%, private companies hold 4.02%, and the general public holds 66.2%.